Reply to Schramm, L. Comment on “Li et al. <i>BDP1</i> Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. <i>Diagnostics</i> 2021, <i>11</i>, 2364”
Xiaoqing Li,
Lan Sun,
Andres Stucky,
Lingli Tu,
Jin Cai,
Xuelian Chen,
Zhongjun Wu,
Xuhong Jiang,
Shengwen Calvin Li
Affiliations
Xiaoqing Li
Department of Oncology, The People’s Hospital of Bishan District, Chongqing 402760, China
Lan Sun
Department of Oncology, The People’s Hospital of Bishan District, Chongqing 402760, China
Andres Stucky
Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
Lingli Tu
Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
Jin Cai
Department of Oral and Maxillofacial Surgery, Zhuhai People’s Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai 519000, China
Xuelian Chen
Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
Zhongjun Wu
Department of Oncology, The People’s Hospital of Bishan District, Chongqing 402760, China
Xuhong Jiang
Department of Health Management, Zhuhai People’s Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai 519000, China
Shengwen Calvin Li
Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, CHOC Children’s Research Institute, Children’s Hospital of Orange County (CHOC), 1201 West La Veta Ave., Orange, CA 92868-3874, USA
